| |
| |
|
| Insider
Information: |
Johnson David Michael |
| Relationship: |
|
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
280,056 |
|
|
Indirect Shares
|
214,672 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
494,728 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Zentalis Pharmaceuticals, Llc |
ZNTL |
Director |
2023-11-10 |
144,389 |
|
0 |
Premium* |
|
|
Aura Biosciences, Inc. |
AURA |
|
2023-11-08 |
135,667 |
2023-11-08 |
214,672 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
21 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ZNTL |
Zentalis Pharmaceuticals,... |
Director |
– • – |
2023-11-10 |
4 |
B |
$9.88 |
$167,943 |
D/D |
17,000 |
144,389 |
2.39 |
- |
|
| AURA |
Aura Biosciences, Inc. |
|
– • – |
2023-11-08 |
4 |
B |
$7.30 |
$146,000 |
I/I |
20,000 |
75,000 |
0.01 |
- |
|
| AURA |
Aura Biosciences, Inc. |
|
– • – |
2023-11-08 |
4 |
B |
$7.30 |
$70,087 |
D/D |
9,601 |
135,667 |
0.01 |
- |
|
| AURA |
Aura Biosciences, Inc. |
|
– • – |
2023-11-07 |
4 |
B |
$7.17 |
$673,980 |
I/I |
94,000 |
65,000 |
0.01 |
- |
|
| AURA |
Aura Biosciences, Inc. |
|
– • – |
2023-11-07 |
4 |
B |
$7.17 |
$544,920 |
D/D |
76,000 |
126,066 |
0.01 |
- |
|
| AURA |
Aura Biosciences, Inc. |
|
– • – |
2023-10-04 |
4 |
B |
$8.61 |
$56,512 |
D/D |
6,566 |
50,066 |
0.01 |
- |
|
| AURA |
Aura Biosciences, Inc. |
|
– • – |
2023-10-03 |
4 |
B |
$8.27 |
$111,663 |
D/D |
13,500 |
43,500 |
0.01 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
Director |
– • – |
2023-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
19,059 |
127,389 |
0 |
- |
|
| AURA |
Aura Biosciences, Inc. |
Director |
– • – |
2023-01-06 |
4 |
B |
$10.50 |
$16,851 |
I/I |
1,604 |
18,000 |
2.1 |
- |
|
| AURA |
Aura Biosciences, Inc. |
Director |
– • – |
2023-01-05 |
4 |
B |
$10.00 |
$3,960 |
I/I |
396 |
17,096 |
2.1 |
- |
|
| AURA |
Aura Biosciences, Inc. |
Director |
– • – |
2022-12-28 |
4 |
B |
$9.75 |
$39,000 |
I/I |
4,000 |
17,000 |
2.1 |
- |
|
| AURA |
Aura Biosciences, Inc. |
Director |
– • – |
2022-12-01 |
4 |
B |
$12.37 |
$123,700 |
I/I |
10,000 |
15,000 |
2.1 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
Director |
– • – |
2022-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
24,871 |
108,330 |
0 |
- |
|
| AURA |
Aura Biosciences, Inc. |
Director |
– • – |
2021-11-02 |
4 |
A |
$0.00 |
$0 |
I/I |
139,672 |
139,672 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
Director |
– • – |
2021-10-04 |
4 |
AS |
$65.95 |
$855,588 |
D/D |
(12,896) |
80,959 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
Director |
– • – |
2021-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
93,855 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
Director |
– • – |
2021-06-04 |
4/A |
A |
$0.00 |
$0 |
D/D |
7,500 |
96,355 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
Director |
– • – |
2020-12-02 |
4 |
AS |
$49.80 |
$662,747 |
D/D |
(12,896) |
101,752 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
Director |
– • – |
2020-04-07 |
4 |
AB |
$18.00 |
$72,000 |
D/D |
4,000 |
114,648 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
Director |
– • – |
2020-04-07 |
4 |
A |
$0.00 |
$0 |
D/D |
51,587 |
110,648 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
Director |
– • – |
2020-04-03 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
59,061 |
|
- |
|
21 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
